20900 ⎘
Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Peptides having 5 to 11 amino acids
Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin
#2402Mitochondrial penetrating peptides as carriers for antimicrobials
#2403Therapy for subarachnoid hemorrhage and ischemia
#2404Compositions and methods for treatment of cancer
#2405Therapeutic agents for regulating serum phosphorus
#2406COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF TOXIC TRANSCRIPTS
#2407COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS
#2408Compositions and methods of inhibiting apoptosis
#2409METHOD OF TREATMENT OF HIV OR AIDS
#2410Use of CHEC peptides to treat neurological and cardiovascular diseases and disorders
#2411Methods for treating pain
#2412Peptides for promoting angiogenesis and use thereof
#2413Peptides for inhibiting chemokine binding to chemokine receptors
#2414Integrin receptor antagonists and their methods of use
#2415CEACAM based antibacterial agents
#2416Methods for treating combined radiation and thermal injury
#2417NEUROPROTECTION USING NAP-LIKE AND SAL-LIKE PEPTIDE MIMETICS
#2418Neuritogenic peptides
#2419Method for treating celiac disease
#2420HMGB1-derived peptides enhance immune response to antigens
#2421Binding ligand linked drug delivery conjugates of tubulysins
#2422Use of the PAT nanopeptide in treating and preventing neurodegenerative diseases
#2423Pea protein peptides with anti activity
#2424Immunotherapy comprising TLR9 ligand and CD40 ligand
#2425Methods and uses of TIE2 binding and/or activating agents
#2426Hybrid hydrogel scaffold compositions and methods of use
#2427Peptides that home to atherosclerotic plaques and methods of use
#2428Use of a peptide fragment of CD44v6 in the treatment of ophthalmic diseases
#2429Peptide and use thereof
#2430Wound healing peptides and methods of use thereof
#2431Antibacterial and antifungal peptides
#2432CANCER RELATED ISOFORMS OF COMPONENTS OF TRANSCRIPTION FACTOR COMPLEXES AS BIOMARKERS AND DRUG TARGETS
#2433METHOD OF TREATING ALZHEIMER'S DISEASE USING PHARMACOLOGICAL CHAPERONES TO INCREASE PRESENILIN FUNCTION AND GAMMA-SECRETASE ACTIVITY
#2434Method for Preventing Myocardial Ischemia
#2435Compounds and their use
#2436Casein derived peptides and uses thereof
#2437PEPTIDE TARGETING OF INNER EAR CELLS
#2438Regulation of skin pigmentation by neuregulin-1 (NRG-1)
#2439Method of treatment of type 2 diabetes
#2440Antimicrobial compositions and methods of use thereof
#2441Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor
#2442Pharmaceutical Compositions
#2443Secreted protein acidic and rich in cysteine (SPARC) protein SRM assay
#2444Compositions and methods for the treatment of asthma and associated disorders
#2445ENHANCED ORAL TRANSCOMPARTMENTAL DELIVERY OF THERAPEUTIC OR DIAGANOSTIC AGENTS
#2446Inhibitors of beta integrin-G protein alpha subunit binding interactions
#2447Cardiovascular therapeutics
#2448IAP BIR domain binding compounds
#2449Integrin interaction inhibitors for the treatment of cancer
#2450Amidated dopamine neuron stimulating peptide restoration of mitochondrial activity
#2451COMPOSITIONS AND METHODS FOR INHIBITING THE INTERACTION BETWEEN CFTR AND CAL
#2452Combination therapies using cyclosporine and aromatic cationic peptides
#2453Inhibitors of mitochondrial fission and methods of use thereof
#2454METHODS OF TREATMENT OF PATIENTS AT INCREASED RISK OF DEVELOPMENT OF ISCHEMIC EVENTS AND COMPOUNDS HEREOF
#2455Compositions and methods of use of targeting peptides against placenta and adipose tissues
#2456Stabilizing alkylglycoside compositions and methods thereof
#2457METHODS OF TREATING OR PREVENTING PERIODONTITIS AND DISEASES ASSOCIATED WITH PERIODONTITIS
#2458Peptidomimetic sulfamide compounds and antiviral uses thereof
#2459Inhibiting peptides derived from TREM-like transcript 1 (TLT-1) and uses thereof
#2460Method of treating prostate cancer with GnRH antagonist
#2461Peptidomimetic sulfamide compounds and antiviral uses thereof
#2462Active scaffolds for on-demand drug and cell delivery
#2463Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances
#2464COMPOSITIONS AND METHODS FOR INHIBITING MMP-9-MEDIATED CELL MIGRATION
#2465Cupredoxin derived transport agents and methods of use thereof
#2466Proteinase K inhibitors, methods and compositions therefor
#2467Joint-homing peptides and uses thereof
#2468Methods for treating atrial or ventricular arrhythmias by administering a G-protein alpha inhibitor
#2469Yellow pea seed protein-derived peptides
#2470Induction of differential stress resistance and uses thereof
#2471Oral delivery of peptide pharmaceutical compositions
#2472Methods and apparatus for guiding medical care based on detected gastric function
#2473Pharmaceutical Compositions Including Low Dosages of Desmopressin
#2474SYNERGISTIC ANTIBIOTIC COMBINATIONS AND DERIVATIVES
#2475Therapeutic use of peptide inhibitors of NADPH oxidase; aerosolization as a delivery mechanism
#2476Method for inhibiting platelet derived growth factor signaling with C3aR or C5aR antibodies
#2477USE OF TRANSFORMING GROWTH FACTOR - BETA 1 (TGF-B1) INHIBITOR PEPTIDES FOR THE TREATMENT OF CORNEAL FIBROSIS AND/OR HAZE
#2478Hemiasterlin derivatives and uses thereof in the treatment of cancer
#2479Methods of treating overproduction of cortisol using ACTH antagonist peptides
#2480METHODS FOR REGULATING BLOOD GLUCOSE LEVELS
#2481Method Of Reducing Injury To Mammalian Cells
#2482Peptidomimetic protease inhibitors
#2483Methods and compositions for amelioration of autoimmune disease using fusion proteins of anti-dendritic cell receptor antibody to peptide sequences
#2484Compositions and methods for the treatment of myocardial ischemia/reperfusion injury with Annexin A1 short peptide
#2485Tumor activated prodrugs
#2486Tumor activated prodrugs
#2487BUFFERED OPHTHALMIC COMPOSITIONS AND METHODS OF USE THEREOF
#2488Depot stent comprising an elastin-based copolymer
#2489Co-administration of an agent linked to an internalization peptide with an anti-inflammatory
#2490SUSTAINED RELEASE FORMULATIONS OF PEPTIDOMIMETIC DRUGS AND USES THEREOF
#2491Methods for promoting wound healing and/or reducing scar formation
#2492Compositions and methods for treatment of eye disorders
#2493Skin cream
#2494Peptide protection against ultraviolet light toxicity
#2495Anti-mesothelin antibodies and immunoconjugates
#2496Use of endostatin peptides for the treatment of fibrosis
#2497Method for repairing DNA damage in keratinocytes
#2498Peptide reagents and methods for detection of colon dysplasia
#2499METHODS AND COMPOSITIONS FOR TARGETING GC1QR/P32
#2500GABA release-regulating agent in cerebellum
#2501Composition for preventing or treating inflammation
#2502Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and improving normal memory
#2503TOPICAL CORNEAL ANALGESIA USING NEUROTENSIN RECEPTOR AGONISTS AND SYNERGISTIC NEUROTENSIN COMBINATIONS WITHOUT DELAYING WOUND HEALING
#2504Method and compositions for treating stroke with fever
#2505TOPICAL CORNEAL ANALGESIA USING NEUROTENSIN RECEPTOR AGONISTS AND SYNERGISTIC NEUROTENSIN COMBINATIONS WITHOUT DELAYING WOUND HEALING
#2506Method of colorectal cancer detection by using radiolabeled anti-GRP78 peptide
#2507Fragment ligated inhibitors selective for the polo box domain of PLK1
#2508DUAL ANTAGONISM OF ENDOTHELIN TYPE A AND BRADYKININ B1 RECEPTORS FOR TREATING PAIN AND PREVENTING CARTILAGE DEGRADATION
#2509Inhibition of TREM receptor signaling with peptide variants
#2510CAPCNA PEPTIDE THERAPEUTICS FOR CANCER
#2511Method of treating cancer with an HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same
#2512ψεrack peptide composition and method for protection against tissue damage due to ischemia
#2513Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction
#2514HCV protease inhibitors and uses thereof
#2515Method for treatment of inflammatory disease and disorder
#2516Inhibition of biofilm organisms
#2517Enhancement of bone morphogenic protein (BMP) retention with BMP binding peptide (BBP)
#2518Analgesic Composition for Transbuccal Administration
#2519TREATMENT OF OVARIAN CANCER USING A SPECIFIC BINDING AGENT OF HUMAN ANGIOPOIETIN-2 IN COMBINATION WITH A TAXANE
#2520METHODS FOR TREATING SEPTIC SHOCK
#2521Treatment of cancers with A-8R peptide
#2522COMPOSITION FOR THE TREATMENT OF BENIGN PROSTATE HYPERPLASIA
#2523Methods and compositions for specific modulation of MCL-1
#2524METHODS AND COMPOSITIONS FOR INHIBITING C-MET DIMERIZATION AND ACTIVATION
#2525Active cores of peptide triazole HIV-1 entry inhibitors
#2526Connective tissue stimulating peptides
#2527COMPOSITIONS AND METHODS FOR THE TREATMENT OF KRABBE AND OTHER NEURODEGENERATIVE DISEASES
#2528Compounds and methods for treating bone disorders and controlling weight
#2529Peptides that down regulate the activity of plasma membrane transporters including sodium-D-glucose cotransporter SGLT1
#2530Methods related to the treatment of neurodegenerative and inflammatory conditions
#2531Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
#2532Anti-Gram Negative Bacteria Agent
#2533AGENT FOR ELIMINATING MULTIDRUG RESISTANCE
#2534Stimulator of genital, sexual and reproductive function
#2535Peptide ligands for G-protein coupled receptors
#2536Personal Care Composition Containing Yeast Extract And Hexapeptide
#2537Methods for detecting and inhibiting angiogenesis
#2538AUTISM TREATMENT
#2539Sincalide Formulations
#2540Methods of treating cancer
#2541Methods for the treatment of X-linked hypophosphatemia and related disorders
#2542Method for treating myocardial ischemia
#2543PAR-1 Activation by Metalloproteinase-1 (MMP-1)
#2544Peptide-based compounds and compositions which inhibit muscle contraction
#2545USE OF CD44V6 IN THE TREATMENT OF OPHTHALMIC DISEASES
#2546Use of specific peptides in the preparation of a medicament for the treatment of monoclonal gammopathy of undetermined significance (MGUS) or of smoldering multiple myeloma (SMM)
#2547COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
#2548Compositions and method for the diagnosis, prevention and treatment of alzheimer's disease
#2549Method of treating tumors
#2550Anti-parasitic compounds
#2551Formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or class II molecules for vaccines
#2552Proteasome-activating lightening peptidic hydrolyzates and compositions containing them
#2553Cosmetic and/or pharmaceutical composition comprising a relieving peptidic hydrolyzate
#2554Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolyzate that can reinforce the barrier function
#2555E2F as a target of hormone refractory prostate cancer
#2556Pharmaceutical compositions and related methods of delivery
#2557Topical Anesthetic Uses of Szeto-Schiller Peptides
#2558Composition for improving brain function and method for improving brain function
#2559Compositions for stimulation of mammalian innate immune resistance to pathogens
#2560Modulation of activity of neurotrophins
#2561Compounds for, and methods of, treating cancer and inhibiting invasion and metastases
#2562Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues
#2563Materials and methods for the treatment of celiac disease
#2564METHOD TO INHIBIT THE BIOLOGICAL ACTIVITY OF CALCINEURIN WITH SELECTIVE PEPTIDES
#2565Methods of treatment using orodispersible desmopressin pharmaceutical formulations
#2566LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized
#2567Sulfation of Wnt pathway proteins
#2568Methods for Hematopoietic Stem Cell Transplantation
#2569Compositions and methods for inhibiting the interaction between CFTR and CAL
#2570COMPOSITIONS AND METHODS FOR TOPICAL APPLICATION AND TRANSDERMAL DELIVERY OF AN OLIGOPEPTIDE
#2571AGR-MEDIATED INHIBITION OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS
#2572Peptidomimetic protease inhibitors
#2573Pharmaceutical preparation to be administered into respiratory organs for treating or preventing inflammatory respiratory diseases, and method for treating or preventing such diseases
#2574COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS
#2575PAR2 agonists for use in the treatment or prevention of influenza virus type A infections
#2576Coating Comprising An Elastin-Based Copolymer
#2577Antagonists of MUC1
#2578COMPOSITIONS AND METHODS FOR INDUCING AN IMMUNE RESPONSE
#2579TRUNCATED CAR PEPTIDES AND METHODS AND COMPOSITIONS USING TRUNCATED CAR PEPTIDES
#2580NON-INVASIVE TOOLS FOR DETECTING VULNERABLE ATHEROSCLEROTIC PLAQUES
#2581Peptides for inhibiting chemokine binding to chemokine receptors
#2582Methods of modulating bromodomains
#2583Controlled-released peptide formulations
#2584Neuroprotective and neurorestorative method and compositions
#2585Cancer antigen eEF2
#2586Peptoid and synthetic oligomers, pharmaceutical compositions and methods of using same
#2587Soothing cosmetic or pharmaceutical composition comprising a peptide which activates HMG-CoA reductase
#2588Method of stimulating the motility of the gastrointestinal system using ipamorelin
#2589COMBINATION THERAPIES USING NAP
#2590Pharmaceutical compositions and related methods of delivery
#2591Method of treatment or prophylaxis
#2592HEALTH SUPPLEMENTS CONTAINING PHYTO-OESTROGENS, ANALOGUES OR METABOLITES THEREOF
#2593Composition Comprising Vascular Endothelial Growth Factor (VEGF) for the Treatment of Hair Loss
#2594Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof
#2595Soothing pharmaceutical or cosmetic composition comprising a peptide that activates HMG-CoA reductase
#2596Uses of an immunomodulatory protein (GMI) from
#2597HLA CLASS I A2 TUMOR ASSOCIATED ANTIGEN PEPTIDES AND VACCINE COMPOSITIONS
#2598Nonapeptide with anti-tumour activity
#2599Method of treatment or prophylaxis
#2600PROPHYLACTIC / THERAPEUTIC AGENT FOR CANCER
#2601CATHEPSIN L PROTEOLYTICALLY PROCESSES HISTONE H3 DURING MOUSE EMBRYONIC STEM CELL DIFFERENTIATION
#2602PHARMACEUTICAL COMPOSITIONS AND METHODS OF DELVERY
#2603Synthetic antigenic peptides and lipopeptides derived from subsp.
#2604HYALURONIC ACID CONTAINING COMPOSITIONS FOR TREATMENT OF WOUNDS, SCARS, POST-SURGICAL ADHESION FORMATION
#2605COMPLEMENT C3a DERIVED DIMERIC PEPTIDES AND USES THEREOF
#2606METHODS OF CHOLESTEROL REDUCTION USING ISOFLAVONES
#2607Compositions and methods for treatment of angiogenesis-associated ocular disorders
#2608PROCESS FOR THE PREPARATION OF ASYMMETRICAL BIS(THIOSEMICARBAZONES)
#2609Cosmetic or pharmaceutical peptides containing uncoded amino acids and their use in the treatment and/or care of the skin, mucous membranes, or scalp
#2610Compositions and methods of use of targeting peptides against placenta and adipose tissues
#2611Utilization of peptides as active ingredients for slimming
#2612Methylation detection of MGMT
#2613Peptides for preventing or treating liver damage
#2614COMPOSITION FOR TREATMENT AND PREVENTION OF HAIR LOSS AND PREMATURE GRAYING OF HAIR
#2615IMMUNOSTIMULATORY COMBINATIONS
#2616Peptides, derivatives and analogs thereof, and methods of using same
#2617Inhibition of gliadin peptides
#2618T-cell immunogens derived from anti-viral proteins and methods of using same
#2619NOVEL ANTI-AGING PEPTIDES AND COSMETIC AND/OR PHARMACEUTICAL COMPOSITION CONTAINING SAME
#2620INHIBITORS OF AMYLOID FIBRIL FORMATION AND USES THEREOF
#2621Method of inhibiting biomaterial-induced procoagulant activity using complement inhibitors
#2622METAL-BINDING COMPOUNDS AND USES THEREFOR
#2623PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH
#2624PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
#2625Complement inhibitors for treatment of injury from intracerebral hemorrhage
#2626Nanoparticles for Use as Synthetic Platelets and Therapeutic Agent Delivery Vehicles
#2627CCN3 peptides and analogs thereof for therapeutic use
#2628Modified peptide that reduces pain in peripheral neuropathy
#2629Methods to prevent and treat diseases
#2630IMPLANTABLE DEVICE FOR THE DELIVERY OF OCTREOTIDE AND METHODS OF USE THEREOF
#2631Somatostatin analogs with inhibitory activity to growth hormone release
#2632Methods of protecting against apoptosis using lipopeptides
#2633TREATMENT OF DISEASES AND CONDITIONS MEDIATED BY INCREASED PHOSPHORYLATION
#2634Treatment of biofilms
#2635Bacterial Polysaccharide-Polypeptide Conjugate Compositions
#2636COAGULATION FACTOR MODULATION FOR CONTROLLING TRANSPLANT ORGAN SIZE
#2637DIRECT DRUG DELIVERY SYSTEM BASED ON THERMALLY RESPONSIVE BIOPOLYMERS
#2638THERAPY AND MEDICAMENT USING INTEGRIN LIGANDS FOR TREATING CANCER
#2639Treatment of diseases and conditions mediated by increased phosphorylation
#2640Method for controlling fibrosis and other pathological deposits in tissues comprising administering a GHRP-6 composition
#2641COMBINATION THERAPY USING RECEPTOR TYROSINE KINASE INHIBITORS AND ANGIOGENESIS INHIBITORS
#2642Treatment of kidney disorders with VIP fragments
#2643Ligands to radiation-induced molecules
#2644Obtaining cocoa extracts rich in bioactive peptides with ACE and PEP enzyme inhibitory activity
#2645METHODS OF TREATING OBESITY USING ENTEROSTATIN
#2646Uses of kappa opioid synthetic peptide amides
#2647SCREENING METHOD FOR POLYMORPHIC MARKERS IN HTRA1 GENE IN NEURODEGENERATIVE DISORDERS
#2648Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
#2649COMBINATION THERAPY FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE, AND KIT THEREFOR
#2650Compositions and methods for inhibiting the interaction between CFTR and CAL
#2651USE OF TIGHT JUNCTION ANTAGONISTS IN THE TREATMENT OF ACUTE LUNG INJURY AND ACUTE RESPIRATORY DISTRESS
#2652Tissue occluding agent comprising an IEIKIEIKIEIKI peptide
#2653Dimeric Smac mimetics
#2654Methods and compositions for treating conditions
#2655Compositions comprising capture peptides for A β-amyloid peptide
#2656Peptides that target dorsal root ganglion neurons
#2657NOVEL ANTIVIRAL COMPOUNDS FROM MARINE EXTRACTS
#2658Antibody Targeting Through a Modular Recognition Domain
#2659METHODS FOR P2RY5 MEDIATED REGULATION OF HAIR GROWTH AND MUTANTS THEREOF
#2660Compositions containing interleukin-1 and peptides
#2661Method of modulating the proliferation of medullary thyroid carcinoma cells
#2662Peptide compositions and therapeutic uses thereof
#2663Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma
#2664Amidated Dopamine Neuron Stimulating Peptides for CNS Dopaminergic Upregulation
#2665Modified peptides as potent inhibitors of the PSD-95/NMDA receptor interaction
#2666OPIORPHIN FOR USE AS A PSYCHOSTIMULANT AGENT
#2667METHODS FOR DETECTING AND INHIBITING ANGIOGENESIS
#2668Compositions and methods for the diagnosis and treatment of tumor
#2669Inducer of chondrocyte proliferation and differentiation
#2670COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNFalpha
#2671Compounds for treating amyloidoses
#2672INHIBITORS OF SERINE PROTEASES
#2673Medical devices
#2674Compositions and methods for treatment
#2675Compositions and methods for treatment
#2676Immunogenic peptides and methods of use
#2677Peptides that home to tumor lymphatic vasculature and methods of using same
#2678Methods and compositions related to clot-binding compounds
#2679Composition for improving brain function and method for improving brain function
#2680Methods and compositions for inhibition of BCL6 repression
#2681Method of treating HIV in drug resistant non plasma viral reservoirs with monomeric DAPTA
#2682Model Systems and Materials for the Study and Treatment of Neurodegenerative Diseases
#2683Nano cancer barrier device (NCBD) to immobilize and inhibit the division of metastic cancer stem cells
#2684TREATMENT OF INFECTIONS AND OTHER DISORDERS
#2685Methods and Compositions Related to GHS-R Antagonists
#2686Transcutaneous delivery of therapeutic agents
#2687Method Of Treating Acute Respiratory Distress Syndrome
#2688Use of tight junction antagonists to treat inflammatory bowl disease
#2689Sustained-release composition and method for producing the same
#2690TREATMENT AND PREVENTION OF DRY AGE-RELATED MACULAR DEGENERATION BY ACTIVATING CD36
#2691Method of treating cancer
#2692Methods and compositions for prostate cancer immunotherapy
#2693Compositions and methods for treating diseases
#2694THYMOSIN BETA 4 PROMOTES WOUND REPAIR
#2695COMBINATORIAL THERAPIES FOR THE TREATMENT OF NEOPLASIAS USING THE OPIOID GROWTH FACTOR RECEPTOR
#2696Antisense antiviral compound and method for treating influenza viral infection
#2697Competitive inhibitors of invariant chain expression and/or ectopic clip binding
#2698Wound healing peptides and methods of use thereof
#2699USE OF ANTIMICROBIAL POLYMERS FOR RE-SENSITIZATION OF MICROORGANISMS UPON EMERGENCE OF RESISTANCE TO ANTI-MICROBIAL AGENTS
#2700Peptides having binding affinity to an antibody which recognizes an epitope on an α1 loop 2 or β2 loop 1 of an adrenoreceptor